首页> 美国卫生研究院文献>Frontiers in Medicine >A Simple Bayesian Method for Evaluating Whether Data From Patients With Rheumatic Diseases Who Have Been Under Chronic Hydroxychloroquine Medication Since Before the COVID-19 Outbreak Can Speak to Hydroxychloroquines Prophylactic Effect Against Infection With SARS-CoV-2

【2h】

A Simple Bayesian Method for Evaluating Whether Data From Patients With Rheumatic Diseases Who Have Been Under Chronic Hydroxychloroquine Medication Since Before the COVID-19 Outbreak Can Speak to Hydroxychloroquines Prophylactic Effect Against Infection With SARS-CoV-2

机译：一种简单的贝叶斯方法用于评估来自慢性羟基氯喹药物的风湿性疾病的数据是否从Covid-19爆发之前达到慢性羟基氯喹药物可以与SARS-COV-2的羟基氯喹对羟基氯喹的预防效果交谈

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Frontiers in Medicine
作者
Serban C. Musca;
展开▼
作者单位

展开▼
年(卷),期 2020(-1),-1
年度 2020
页码 -1
总页数 6
原文格式 PDF
正文语种
中图分类情报学;
关键词

机译：SARS-COV-2 / Covid-19;羟基氯喹;慢性药物;预防效果;全身狼疮红斑;类风湿性关节炎;Clemastine;Cloperastine;
入库时间 2022-08-21 12:10:35

相似文献

外文文献
中文文献
专利

1. A Simple Bayesian Method for Evaluating Whether Data From Patients With Rheumatic Diseases Who Have Been Under Chronic Hydroxychloroquine Medication Since Before the COVID-19 Outbreak Can Speak to Hydroxychloroquine's Prophylactic Effect Against Infection With SARS-CoV-2 [J] . Serban C. Musca Frontiers in Medicine . 2020,第a期

机译：一种简单的贝叶斯方法，用于评估来自慢性羟基氯喹药物的风湿病患者是否在Covid-19爆发之前，可以与SARS-COV-2对羟基氯喹的预防效果交谈
2. A Simple Bayesian Method for Evaluating Whether Data From Patients With Rheumatic Diseases Who Have Been Under Chronic Hydroxychloroquine Medication Since Before the COVID-19 Outbreak Can Speak to Hydroxychloroquine's Prophylactic Effect Against Infection With SARS-CoV-2 [J] . Musca Serban C. Frontiers in Medicine . 2020,第2期

机译：一种简单的贝叶斯方法，用于评估来自慢性羟基氯喹药物的风湿性疾病的数据是否从Covid-19爆发之前达到慢性羟基氯喹药物，可以与SARS-COV-2的羟基氯喹对羟基氯喹的预防效果交谈
3. Can hydroxychloroquine protect patients with rheumatic diseases from COVID-19? Response to: 'Does hydroxychloroquine prevent the transmission of COVID-19?' by Heldwein and Calado and 'SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment' by Joob and Wiwanitkit [J] . Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2020,第6期

机译：羟基氯喹可以保护患者免受Covid-19的风湿性疾病吗？回应：'羟基氯喹是否防止了Covid-19的传输？' 通过Holdwein和Calado和'SLE，羟基氯喹，没有Covid-19的SLE患者：评论'由Joob和Wiwanitkit
4. Visual Exploration of Time-Oriented Patient Data for Chronic Diseases: Design Study and Evaluation [C] . Alexander Rind, Wolfgang Aigner, Silvia Miksch, Information quality in e-health . 2011

机译：面向时间的慢性病患者数据的可视化探索：设计研究和评估
5. Understanding, evaluating and enhancing electronic medical record adoption in a primary caresetting: A programme to improve electronic medical record data quality and its effect on familypractice provision of incentivized and enhanced care for chronic disease patients [D] . Bowen, Michael. 2013

机译：了解，评估和增强在初级护理环境中采用电子病历的方案：一项旨在提高电子病历数据质量及其对家庭实践的激励措施的计划，该方案为慢性病患者提供激励和加强护理
6. Failure of chronic hydroxychloroquine in preventing severe complications of COVID-19 in patients with rheumatic diseases [O] . Khanh Pham, Heidi Torres, Michael J Satlin, 2021

机译：慢性羟基氯喹对患有风湿病患者Covid-19严重并发症的失败
7. Can hydroxychloroquine protect patients with rheumatic diseases from COVID-19? Response to: ‘Does hydroxychloroquine prevent the transmission of COVID-19?’ by Heldwein and Calado and ‘SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment’ by Joob and Wiwanitkit [O] . Sara Monti, Carlomaurizio Montecucco 2020

机译：羟基氯喹可以保护患者免受Covid-19的风湿性疾病吗？回应：'羟基氯喹是否通过Holdwein和Calado和'SLE，羟基氯喹和没有Covid-19的SLE，羟基氯喹和No SLE-19：评论'评论'，通过joob和wiwanitkit来传播Covid-19？'

A Simple Bayesian Method for Evaluating Whether Data From Patients With Rheumatic Diseases Who Have Been Under Chronic Hydroxychloroquine Medication Since Before the COVID-19 Outbreak Can Speak to Hydroxychloroquines Prophylactic Effect Against Infection With SARS-CoV-2

著录项

相似文献

相关主题

期刊订阅